Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Independent evaluation finds GAVI funding to poor countries can boost childhood vaccine coverage

19.09.2006
But countries with initial coverage greater than 65% showed no effect

The Global Alliance for Vaccines and Immunization (GAVI) was created in 1999 with the goal of enabling even the poorest countries to provide vaccines to all children. A study by researchers associated with the Harvard Initiative for Global Health set out to measure the extent to which GAVI funding had succeeded in raising the percentage of children who received the combined diphtheria, tetanus and pertussis vaccine (DTP3) and whether the cost had been close to GAVI's original estimates of $20 per additional child immunized.

Their analysis appears in advance online in the September 21, 2006 issue of the Lancet, www.thelancet.com.

GAVI is a public-private global health partnership that was created when vaccine coverage in many countries was dropping. Countries with a gross national income of less than US$1000 per capita per year and with coverage under 80% were eligible to receive financial support from GAVI to develop immunization services, including personnel, infrastructure and supplies, as part of their national health system. Decisions on how resources are spent are left to the individual countries, but continued authorization of funding is tied to meeting yearly immunization coverage targets set by the countries.

Research Associate Chunling Lu and colleagues from the Harvard School of Public Health (HSPH) analyzed the relationship between DTP3 coverage for GAVI recipient countries from 1995 to 2004 and immunization services spending (ISS) per surviving child in 53 countries. The analysis revealed that in countries with DTP3 coverage of 65% or less at the start of the program, ISS spending had a significant positive effect on DTP3 coverage, raising coverage from under 50% in many countries to close to 65%.

However, in countries with initial DTP3 coverage of more than 65%, GAVI spending did not translate into increased immunization coverage.

The estimated cost per additional child immunized was less than $14. But if non-ISS expenditures are included, such as for new and underused vaccine and safe injection equipment, the cost per child approaches $20, close to GAVI's original estimates.

Between 2000 and 2005, total GAVI disbursements were $760.5 million, of which $124-125 million (16%) were for immunization services spending.

Based on their analysis, the researchers recommend that GAVI consider redistributing its resources to countries with the lowest immunization coverage.

"Assessment of the effect of GAVI is important not only because of the alliance's mission and the resources devoted to this effort," write the researchers, "but also because the project represents an important innovation in global health. Together with Stop TB and Roll Back Malaria, GAVI was one of the first major global health initiatives designed to create new public-private partnerships to tackle major health problems."

Unlike these other global health initiatives, however, for which there is no reliable indicator of effect on health, GAVI afforded an opportunity for concrete measure of public health improvement.

"This is the first time that there is hard evidence that one of the major global health programs is having a real impact; the world desperately needs similar analyses for AIDS, tuberculosis, malaria and other initiatives," said senior author Christopher J. Murray, Richard Saltonstall Professor of Population Policy at HSPH and director of the Harvard Initiative for Global Health.

Said Lu: "Our research shows conclusively that GAVI, as an experiment to provide financial help to countries with poor performance in DTP3 coverage, is effective in bringing vaccine protection to the world's most disadvantaged children."

Todd Datz | EurekAlert!
Further information:
http://www.hsph.harvard.edu

More articles from Studies and Analyses:

nachricht Europe’s Demographic Future. Where the Regions Are Heading after a Decade of Crises
10.08.2017 | Berlin-Institut für Bevölkerung und Entwicklung

nachricht Scientists reveal source of human heartbeat in 3-D
07.08.2017 | University of Manchester

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

Nagoya physicists resolve long-standing mystery of structure-less transition

21.08.2017 | Materials Sciences

Chronic stress induces fatal organ dysfunctions via a new neural circuit

21.08.2017 | Health and Medicine

Scientists from the MSU studied new liquid-crystalline photochrom

21.08.2017 | Materials Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>